Development and validation of microbial bioassay for the quantification of potency of the antibiotic cefuroxime axetil

Analytical Methods

Volumn 5, Issue 3, 2013, Pages 690-698

  Dafale, Nishant A ^a   Agarwal, Piyush K ^a   Semwal, Uttam P ^a   Singh, G N ^a  

^a Indian Pharmacopoeia Commission   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; COMMERCE;

ANTI-MICROBIAL ACTIVITY; HPLC METHOD; MICROBIAL STRAIN; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE DETERMINATIONS;

BIOASSAY;

EID: 84872507654     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/c2ay25848j     Document Type: Article

References (28)

1. C. A. Schmidt D. A. Agarrayua L. V. Laporta J. C. Machado M. L. Manfio C. F. Bittencourt J. Microbiol. Methods 2009 77 308 315
2. Indian Pharmacopoeia, 2010, pp. 49-56/1026-1028
3. B. Ayres, M. Cook, B. Davis, G. Gregory, C. Newall, D. Pearce, G. Phillips and N. Weir, 1973, Novel 21-acyloxy-3α-hydroxy-5α-pregnone- 11,20-diones-anesthetics, Patent Assignees(s): Glaxo Laboratories Ltd, US Patent no. 3763195
4. C. H. O'Callaghan R. B. Skyes D. M. Ryan R. D. Foord P. W. Muggleton J. Antibiot. 1976 29 1 29 37
5. H. Onishi D. R. Daoust S. B. Zimmerman D. Hendlin E. Stapley Antimicrob. Agents Chemother. 1974 5 1 38 48
6. C. M. Ginsburg G. H. McCracken M. Petruska K. Olson Antimicrob. Agents Chemother. 1985 28 4 504 507
7. L. J. Scott D. Ormrod K. L. Goa Drugs 2001 61 10 1455
8. N. C. James K. H. Donn J. J. Collins I. M. Davis T. L. Lloyed R. Hart J. R. Powell Antimicrob. Agents Chemother. 1991 35 1860 1863
9. Glaxo Research Ltd The microbiological assay of Cefuroxime. Microbiology division Proc. R. Soc. Med. 1977 70 195 196
10. A. F. M. El-Walily A. A. Gazy S. F. Belal E. F. Khamis J. Pharm. Biomed. Anal. 2000 22 385 392
11. M. J. Souza R. R. Kulmann L. M. Silva D. R. Nogueria E. S. Zimmermann C. A. Schmidt J. Assoc. Anal. Com. Int. 2006 89 1367 1372
12. United States Pharmacopoeia, 2009, pp. 86-93/103-115/1863-1865
13. British Pharmacopoeia, 2011, pp. 432-433/2542/A348-A355
14. E. C. L. Cazedey H. R. N. Salgado Pharmaceutics 2011 3 3 572 581
15. K. E. Cooper A. H. Lindon J. Gen. Microbiol. 1952 7 8 17
16. J. H. Humphrey J. W. Lightbown J. Gen. Microbiol. 1952 7 120 143
17. E. P. Abraham A. D. Gardner E. Chain C. M. Fletcher Lancet 1941 238 177 189
18. J. J. Gavin Appl. Microbiol. 1956 5 II 25 33
19. R. D. Pearson R. T. Steigbigel H. T. Davis Curr. Microbiol. 1980 53 329 334
20. A. W. Bauer W. M. M. Kirby J. C. Sherris M. Truck Am. J. Clin. Pathol. 1966 45 493 496
21. J. S. Simon E. J. Yin Appl. Microbiol. 1970 19 4 573 579
22. K. M. Queiroz M. L. M. Silva N. D. Prado P. M. A. Lima R. D. L. Diniz I. C. Cesar G. A. Pianetti D. A. Santos Braz. J. Pharm. Sci. 2009 45 4 693 700
23. V. P. Shah K. K. Midha J. W. A. Findlay H. M. Hill J. D. Hulse I. J. McGilverary G. Mckay K. J. Miller R. N. Patnaik M. L. Powell A. Tonelli C. T. Viswanathan A. Yacobi Pharm. Res. 2000 17 1551 1557
24. N. A. Hodjes, Pharmaceutical applications of microbiological techniques, in Pharmaceutics: The Science of Dosage Form Design, ed., M. E. Aulton, Churchill Livingstone, London, 9th edn, 2001, pp. 623-643
25. S. Goto The in vitro and in vivo antibacterial activity of cefuroxime Proc. R. Soc. Med. 1977 70 9 56 62
26. F. V. Thompson Acta Pathol. Microbiol. Scand. 1964 61 303 316
27. G. L. Wood and J. A. Washington, Antibacterial susceptibility tests: Dilution and disk diffusion methods, Manual of Clinical Microbiology, American Society for Microbiology Press, Washington DC, 6th edn, 1995, pp. 1327-1341
28. N. Sultana M. S. Arayne Pak. J. Pharm. Sci. 2002 15 2 41 50